Idenix Pharmaceuticals
Discovery and development of drugs for the treatment of human viral diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€3.5b (Public information from Jun 2014)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | - | |
N/A | $140m | IPO | |
$20.0m | Late VC | ||
N/A | $5.0m | Late VC | |
$107m | Post IPO Equity | ||
$3.9b Valuation: $3.9b | Acquisition | ||
Total Funding | €22.7m |
Recent News about Idenix Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.